Pedro Piedra MD
Professor, Virology & Microbiology, Baylor College of Medicine
Join to View Full Profile
One Baylor PlazaMS BCM 280Houston, TX 77030
Phone+1 713-798-5240
Dr. Piedra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University at BuffaloFellowship, Pediatric Infectious Diseases, 1984 - 1987
Medical University of South CarolinaResidency, Pediatrics, 1981 - 1984
University of South Florida College of MedicineClass of 1981
Certifications & Licensure
TX State Medical License 1988 - 2027
SC State Medical License 1982 - 1984
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.Heidi L Moline, Ariana P Toepfer, Ayzsa Tannis, Geoffrey A Weinberg, Mary A Staat
JAMA Pediatrics. 2025-02-01 - Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load.Vasanthi Avadhanula, Chad J Creighton, Laura Ferlic-Stark, Divya Nagaraj, Yiqun Zhang
Plos One. 2025-01-01 - 4 citationsInfant-derived human nasal organoids exhibit relatively increased susceptibility, epithelial responses, and cytotoxicity during RSV infection.Gina M Aloisio, Divya Nagaraj, Ashley M Murray, Emily M Schultz, Trevor McBride
The Journal of Infection. 2024-12-01
Other
- Respiratory Syncytial Virus Fusion Nanoparticle Vaccine Immune Responses Target Multiple Neutralizing Epitopes That Contribute to Protection Against Wild-Type and Pali...Pedro Piedra, MD, ScienceDirect
https://www.doximity.com/articles/ec82b951-b191-4406-8038-7129da66ac6c
UpToDate, Wolters Kluwer Health - 2013-03-13 - Respiratory Syncytial Virus Fusion Nanoparticle Vaccine Immune Responses Target Multiple Neutralizing Epitopes That Contribute to Protection Against Wild-Type and Pali...Pedro Piedra, MD, ScienceDirect
https://www.doximity.com/articles/ec82b951-b191-4406-8038-7129da66ac6c
UpToDate, Wolters Kluwer Health - 2013-01-09
Press Mentions
Texas Measles Outbreak Grows to 223 Cases, with Another 33 in New MexicoMarch 11th, 2025
More Information Needed Amid Paused RSV Vaccine for Children, FDA Committee SaysDecember 14th, 2024
FluMist: Who Is the Nasal Spray Best For?October 22nd, 2024- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
